According to a report by Oriental Daily on August 1st, the Malaysian Ministry of Health is expected to implement the "2024 Public Health Smoking Control Act" (Act 852) as early as the end of this year.
Health Minister Datuk Seri Zulkifli stated that the regulations include several provisions related to registration, sales, packaging, labeling, and orders to prohibit smoking in public places.
The bill has been submitted to the Attorney General's Chambers (AGC) and is currently in the final stage.
The minister stated that everything is ready, may still need some organizing, and hopes to fully implement the legislation by the end of this year.
He emphasized that all relevant regulations will be enforced in conjunction with Act 852, which includes regulations for e-cigarette products.
The upcoming rules and regulations will also cover e-cigarettes and will impose stricter controls on the sale of e-cigarette products to minors.
According to previous reports from the media, the bill aims to strengthen control over the sale of e-cigarette products to minors, and to fundamentally change smoking habits in both government and society.
As of June last year, the Ministry of Health received a total of 17 cases of lung diseases caused by e-cigarettes or related products (EVALI). Meanwhile, from 2015 to August 2023, a total of 69 cases of children poisoning from e-cigarettes have been reported.
On May 30th of last year, a case of poisoning was reported in Pahang State, Malaysia, where a 2-year-old girl experienced acute nicotine poisoning after ingesting the e-liquid from a disposable e-cigarette device.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
